BONE MARROW-DERIVED MESENCHYMAL STEM CELL THERAPY IN CHRONIC KIDNEY DISEASE: AN EARLY PHASE CLINICAL TRIAL

Autor:	Elhusseiny, K., Alatta, L., Snow, Z.K., Skaff, C., Yin, M., Aslam, N., Porter, I., Mao, M., Trautman, C., Baker, L., Manohar, S., Chebib, F., Lorenz, E., Hickson, L.
Zdroj:	In Cytotherapy June 2024 26(6) Supplement:S48-S48
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect